Chandrakasan, S., Allen, C. E., Bhatla, D., Carter, J., Chien, M., Cooper, R., Draper, L., Eckstein, O. S., Hanna, R., Hays, J. A., Hermiston, M. L., Hinson, A. P., Hobday, P. M., Isakoff, M. S., Jordan, M. B., Leiding, J. W., Modica, R., Nakano, T. A., … Oladapo, A. (2025). Emapalumab treatment in rheumatologic disease-associated hemophagocytic lymphohistiocytosis: a plain language summary. Immunotherapy, 17(7), 461–478. https://doi.org/10.1080/1750743x.2025.2509478

Song, J., Morgan, A. A., Ahn, J., Li, W. F., Chang, Y., Chang, Y.-C., Fahimuddin, M., Chi, K.-Y., Wu, L. W., & Chiang, C.-H. (2025). Validating Khorana Risk Score in gastric cancer patients on immune checkpoint inhibitors and chemotherapy. Immunotherapy, 17(6), 419–424. https://doi.org/10.1080/1750743x.2025.2501922

Tzivelekis, S., Orange, J., Poulos, C., Meckley, L. M., Peay, H., Sutphin, J., Hernandez-Trujillo, V. P., & Wasserman, R. L. (2023). Development of A Novel Shared Decision Making Aid for Primary Immunodeficiency Diseases. Immunotherapy, 15(9), 647–656. https://doi.org/10.2217/imt-2022-0193